TERPS Trial for de Novo Oligometastic Prostate Cancer
Part of paid clinical trials in La Jolla, California.
- Sponsor
- University of Maryland, Baltimore
- Study ID
- NCT05223803
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Oligometastatic Disease
- Prostate Cancer
Eligibility Criteria
- Sex
- MALE
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Prostate radiation (XRT) — RADIATIONBoth arms will receive prostate radiation. Multiple treatment regimens are allowed per protocol.
- Systemic Therapy — DRUGAll systemic therapy is provided as best prescribed for patient per their medical oncologist.
- Stereotactic ablative radiation therapy (SABR) — RADIATIONSABR is delivered to those randomized to Arm 2.
Study Details
This research is being done to see if we can improve the outcome of prostate cancer patients who present with metastatic lesions at initial diagnosis.
Key Dates
- Start date
- Oct 18, 2022
- Status verified
- May 2026
- Primary completion
- Jul 31, 2028
- Completion
- Jul 31, 2029
Study Design
- Enrollment
- 122 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Active Comparator: Best systemic therapy (BST) + primary prostate radiation (XRT)
- Active Comparator: BST + XRT + SABR metastasis-directed therapy (MDT)
Primary Outcome Measure
To determine the 2-year failure-free survival (FFS) of men who have oligometastatic prostate cancer with BST+XRT versus BST+XRT+SABR MDT. [ Time Frame: 2 years ]
Central Contacts
- Zaker Rana, MD410-369-5200
- Nicole Helie410-328-6304
Locations (10)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| UC San Diego Moores Cancer Center | La Jolla | California | 92093 | |
| KU Medical Center- Cancer Center | Kansas City | Kansas | 66160 | |
| Maryland Proton Treatment Center | Baltimore | Maryland | 21201 | |
| UMMC | Baltimore | Maryland | 21201 | |
| Upper Chesapeake Health | Bel Air | Maryland | 21014 | |
| Central Maryland Radiation Oncology | Columbia | Maryland | 21044 | |
| Baltimore Washington Medical Center | Glen Burnie | Maryland | 21061 | |
| Sidney Kimmel Cancer Center at Jefferson Health | Philadelphia | Pennsylvania | 19107 | |
| UPMC Hillman Cancer Center | Pittsburgh | Pennsylvania | 15232 | |
| Bon Secours Cancer Institute at St. Francis | Midlothian | Virginia | 23114 |
Find similar trials in La Jolla, CA
By condition
By specialty
Related Studies
- Collection of Blood From Patients With CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Use of Tracking Devices to Locate Abnormalities During Invasive ProceduresEnrolling By Invitation · National Institutes of Health Clinical Center (CC) · Bethesda, Maryland
- Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer StudiesRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland
- Collection of Blood From Patients With Prostate CancerRecruiting · National Cancer Institute (NCI) · Bethesda, Maryland